Day: July 30, 2024

PRESS RELEASE 30 July 2024, Copenhagen, DenmarkThis new FLSmidth order will contribute to an increased supply of lithium, which is required for electric vehicle battery production. Based on extensive ore testing and preliminary equipment designs, the technologies that FLSmidth will deliver will help reduce operating costs for the customer. The order is valued at approximately DKK 340 million and was booked in Q3 2024. The FLSmidth equipment is due to be delivered during 2025/2026 and will provide attractive Service potential in the longer run. FLSmidth has received an order to deliver nine thickeners and six filters to a greenfield lithium project in Nevada, US. A key requirement in the development of this large lithium deposit is to utilise the most efficient process technologies with the lowest environmental impact, leading the customer...

PRESS RELEASE                                         Share Buyback Transaction Details July 25 – July 29, 2024 Alphen aan den Rijn – July 30, 2024 – Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 91,279 of its own ordinary shares in the period from July 25, 2024, up to and including July 29, 2024, for €14.1 million and at an average share price of €155.00. These repurchases are part of the share buyback program announced on February 21, 2024, under which we intend to repurchase shares for €1 billion during 2024. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2024Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)...

A Conversation on Artificial Intelligence, Renewable Energy, and Sustainable Innovation with Dr. Carol Parish SANTA CLARITA, Calif., July 30, 2024 (GLOBE NEWSWIRE) — NewHydrogen, Inc. (OTCMKTS:NEWH), the developer of ThermoLoop™, a breakthrough technology that uses water and heat rather than electricity to produce the world’s cheapest green hydrogen, today announced that in a recent episode of the NewHydrogen Podcast, Steve Hill, CEO of New Hydrogen, explored cutting-edge advancements in hydrogen storage solutions with Dr. Carol Parish, the Floyd D. and Elisabeth S. Gottwald Professor of Chemistry at the University of Richmond. The conversation delved into groundbreaking advancements in hydrogen storage solutions, particularly the role of artificial intelligence (AI) in optimizing room temperature hydrogen storage. Dr. Parish,...

REXEL’S FIRST HALF 2024 FINANCIAL REPORT  MADE AVAILABLE Rexel’s first-half 2024 financial report was filed on July 30, 2024 with the French Autorité des marches financiers (AMF). It is also made available on Rexel’s corporate website (https://www.rexel.com/en) in the “Investors –Regulated Information” section. ABOUT REXEL GROUP Rexel, worldwide expert in the multichannel professional distribution of products and services for the energy world, addresses three main markets: residential, commercial, and industrial. The Group supports its residential, commercial, and industrial customers by providing a tailored and scalable range of products and services in energy management for construction, renovation, production, and maintenance. Rexel operates through a network of more than 1,950 branches in 19 countries, with more than 26,500 employees....

H1 2024 results fully in line with FY planned trajectoryH1 2024 revenue growth of +19.6% in constant currencies, reaching € 86.6 million Adjusted EBITDA margin representing 33.5% of revenue Strong cash conversion representing 127% of adjusted EBITDA Solid commercial traction with existing clients and new logos translating to record high commercial pipeline 2024 objectives confirmedParis, France, July 30, 2024 – Planisware, a leading B2B provider of SaaS in the rapidly growing Project Economy market, announces today its financial results for H1 2024. Revenue amounted to € 86.6 million, up by +19.3% in current currencies, mainly led by the continued success of the Group’s market-leading SaaS platform. In constant currencies, revenue growth reached +19.6% (€+14.2 million), in line with the trajectory expected for the year and the 2024...

 Q2 SALES & H1 2024 RESULTS Sequential organic sales improvement between Q1 and Q2 Resilient profitability and record FCF generation in H1 24, supported by strong discipline and self-help plans 2024 outlook confirmed – in the lower end of the range→ Q2 24 sales up +1.8% on a reported basis, driven by our M&A strategy in Europe and North America → H1 24 sales of €9,629.7m, down (3.5)% on a same-day basis, with a gradual improvement in the period:Q2 24 down (2.4)% after (4.6)% in Q1 24, notably from easier base effect on electrification Improving activity month after month→ Ramp-up of digital sales, to 31% of sales in Q2 24, up +290bps, fostering future productivity gains → H1 24 adjusted EBITA margin resilience at 6.0%, supported by our productivity gains and cost initiatives → H1 24 operating income of €576.8 million...

Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept, and robust retinal drying with Vabysmo Additional submitted data shows that up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months Vabysmo is already approved in several countries, including the US and Japan, for RVO and in nearly 100 countries for people with nAMD and DMEBasel, 30 July 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved Vabysmo® (faricimab) for the treatment of visual impairment due to macular edema secondary to retinal vein occlusion (RVO, branch RVO or central RVO). RVO is the third indication for Vabysmo in the European Union, in...